Toward immunosuppressive effects on liver transplantation in rat model: Tacrolimus loaded poly(ethylene glycol)-poly(d,l-lactide) nanoparticle with longer survival time

International Journal of Pharmaceutics

Volumn 460, Issue 1-2, 2014, Pages 173-180

  Xu, Wei ^a,b   Ling, Peixue ^a,c   Zhang, Tianmin ^c  

^a SHANDONG UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^c Institute of Biopharmaceuticals of Shandong Province   (China)

Author keywords

Immunosuppressive; Liver transplantation; MPEG PLA; Nanoparticle; Tacrolimus

Indexed keywords

COPOLYMER; MACROGOL; NANOPARTICLE; TACROLIMUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; ELECTRON MICROSCOPE; EMULSION; ENCAPSULATION; HUMAN; IN VITRO STUDY; LIVER TRANSPLANTATION; MALE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; SURVIVAL TIME; TRANSMISSION ELECTRON MICROSCOPY;

IMMUNOSUPPRESSIVE; LIVER TRANSPLANTATION; MPEG-PLA; NANOPARTICLE; TACROLIMUS;

ANIMALS; CELL SURVIVAL; DRUG CARRIERS; HEK293 CELLS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PARTICLE SIZE; POLYESTERS; POLYETHYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; TACROLIMUS;

EID: 84892446429     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.10.035     Document Type: Article

References (32)

1. A.Y. Alemdar, K.A. Baker, D. Sadi, V.C. McAlister, and I. Mendez Liposomal tacrolimus administered systemically and within the donor cell suspension improves xenograft survival in hemiparkinsonian rats Exp. Neurol. 172 2001 416 424 (Pubitemid 34075090)
2. H. Arima, K. Yunomae, K. Miyake, T. Irie, F. Hirayama, and K. Uekama Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats J. Pharm. Sci. 90 2001 690 701 (Pubitemid 32530445)
3. K. Avgoustakis Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery Curr. Drug Deliv. 1 2004 321 333
4. F. Danhier, E. Ansorena, J.M. Silva, R. Coco, A. Le Breton, and V. Préat PLGA-based nanoparticles: an overview of biomedical applications J. Control. Release 161 2012 505 522
5. A. Frank, S.K. Rath, and S.S. Venkatraman Controlled release from bioerodible polymers: effect of drug type and polymer composition J. Control. Release 102 2005 333 344 (Pubitemid 40093757)
6. S. Gao, J. Sun, D. Fu, H. Zhao, M. Lan, and F. Gao Preparation, characterization and pharmacokinetic studies of tacrolimus-dimethyl-beta- cyclodextrin inclusion complex-loaded albumin nanoparticles Int. J. Pharm. 427 2012 410 416
7. E.K. Geissler, and H.J. Schlitt Immunosuppression for liver transplantation Gut 58 2009 452 463
8. C. Gong, S. Deng, Q. Wu, M. Xiang, X. Wei, L. Li, X. Gao, B. Wang, L. Sun, Y. Chen, Y. Li, L. Liu, Z. Qian, and Y. Wei Improving antiangiogenesis and anti-tumor activity of curcumin by biodegradable polymeric micelles Biomaterials 34 2013 1413 1432
9. G. Levy, F. Villamil, D. Samuel, F. Sanjuan, G.L. Grazi, Y. Wu, P. Marotta, O. Boillot, F. Muehlbacher, and G. Klintmalm Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation Transplantation 77 2004 1632 1638 (Pubitemid 38780525)
10. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Control. Release 65 2000 271 284 (Pubitemid 30122932)
11. E. Matevossian, D. Doll, N. Hüserm, R. Brauerm, I. Sinicina, J. Nährig, H. Friess, M. Stangl, and V. Assfalg Liver transplantation in the rat: single-center experience with technique, long-term survival, and functional and histologic findings Transplant. Proc. 41 2009 2631 2636
12. K.F. Murray, and R.L. Carithers Jr. AASLD practice guidelines: evaluation of the patient for liver transplantation Hepatology 41 2005 1407 1432 (Pubitemid 40770295)
13. S. Nicolai, and S. Bunyavanich Hypersensitivity reaction to intravenous but not oral tacrolimus Transplantation 94 2012 e61 e63
14. J.G. O'Grady, A. Burroughs, P. Hardy, D. Elbourne, and A. Truesdale Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial Lancet 360 2002 1119 1125
15. H. Okada, and H. Toguchi Biodegradable microspheres in drug delivery Crit. Rev. Ther. Drug Carrier Syst. 12 1995 1 99
16. Y. Peng, J.P. Gong, L.N. Yan, S.B. Li, and X.H. Li Improved two-cuff technique for orthotopic liver transplantation in rat Hepatobiliary Pancreat. Dis. Int. 3 2004 33 37 (Pubitemid 38256121)
17. R. Pichlmayr, M. Winkler, P. Neuhaus, P. McMaster, R. Calne, G. Otto, R. Williams, C.G. Groth, and H. Bismuth Three-year follow-up of the European Multicenter Tacrolimus (FK506) Liver Study Transplant. Proc. 29 1997 2499 2502 (Pubitemid 27373803)
18. A.A. Pillai, and J. Levitsky Overview of immunosuppression in liver transplantation World. J. Gastroenterol. 15 2009 4225 4233
19. S. Pratschke, M. Bilzer, U. Grützner, M. Angele, A. Tufman, K.W. Jauch, and R.J. Schauer Tacrolimus preconditioning of rat liver allografts impacts glutathione homeostasis and early reperfusion injury J. Surg. Res. 176 2012 309 316
20. S.B. Shin, H.Y. Cho, D.D. Kim, H.G. Choi, and Y.B. Lee Preparation and evaluation of tacrolimus-loaded nanoparticles for lymphatic delivery Eur. J. Pharm. Biopharm. 74 2010 164 171
21. Y. Song, L. Zhang, W. Gan, J. Zhou, and L. Zhang Self-assembled micelles based on hydrophobically modified quaternized cellulose for drug delivery Colloids Surf. B: Biointerfaces 83 2011 313 320
22. Y. Takamatsu, M. Ishizu, I. Ichinose, K. Ogata, M. Onoue, M. Kumagawa, J. Suzumiya, and K. Tamura Intravenous cyclosporine and tacrolimus caused anaphylaxis but oral cyclosporine capsules were tolerated in an allogeneic bone marrow transplant recipient Bone Marrow Transplant. 28 2001 421 423 (Pubitemid 32834365)
23. A.L. Taylor, C.J. Watson, and J.A. Bradley Immunosuppressive agents in solid organ transplantation: mechanisms of action and therapeutic efficacy Crit. Rev. Oncol. Hematol. 56 2005 23 46 (Pubitemid 41278644)
24. V.P. Torchilin Micellar nanocarriers: pharmaceutical perspectives Pharm. Res. 24 2007 1 16 (Pubitemid 44902565)
25. T. Ueno, Y. Takama, K. Masahata, S. Uehara, S. Ibuka, H. Kondou, Y. Hasegawa, and M. Fukuzawa Conversion to prolonged-release tacrolimus for pediatric living related donor liver transplant recipients Transplant. Proc. 45 2013 1975 1978
26. M. Vicari-Christensen, S. Repper, S. Basile, and D. Young Tacrolimus: review of pharmacokinetics, pharmacodynamics, and pharmacogenetics to facilitate practitioners' understanding and offer strategies for educating patients and promoting adherence Prog. Transplant. 19 2009 277 284
27. Y. Wang, C. Wang, S. Fu, Q. Liu, D. Dou, H. Lv, M. Fan, G. Guo, F. Luo, and Z. Qian Preparation of tacrolimus loaded micelles based on poly(varepsilon-caprolactone)-poly(ethylene glycol)-poly(varepsilon- caprolactone) Int. J. Pharm. 407 2011 184 189
28. R.H. Wiesner A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group Transplantation 66 1998 493 499 (Pubitemid 28415377)
29. R.H. Wiesner, and J.J. Fung Present state of immunosuppressive therapy in liver transplant recipients Liver Transplant. 17 2011 S1 S9
30. S.H. Wong Therapeutic drug monitoring for immunosuppressants Clin. Chim. Acta 313 2001 241 253 (Pubitemid 33016717)
31. H. Xin, X. Jiang, J. Gu, X. Sha, L. Chen, K. Law, Y. Chen, X. Wang, Y. Jiang, and X. Fang Angiopep-conjugated poly(ethylene glycol)-co-poly(epsilon- caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma Biomaterials 32 2011 4293 4305
32. X. Zheng, B. Kan, M. Gou, S. Fu, J. Zhang, K. Men, L. Chen, F. Luo, Y. Zhao, X. Zhao, Y. Wei, and Z. Qian Preparation of MPEG-PLA nanoparticle for honokiol delivery in vitro Int. J. Pharm. 386 2010 262 267